Restasis Alternatives
Drugs like Restasis (cyclosporine ophthalmic emulsion) — other eye health medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.
Unverified catalogue summary (alternative grouping) for Restasis in US; not checked against current local product information.
Xiidra
lifitegrast · Bausch & Lomb Americas Inc. (US distributor)
Treats Dry eye disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Xiidra in US; not checked against current local product information.
Eylea
aflibercept · Regeneron
Treats Wet macular degeneration, diabetic eye disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Eylea in US; not checked against current local product information.
Vabysmo
faricimab-svoa · Genentech (Roche)
Treats Wet macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion
Unverified catalogue summary (alternative identity, manufacturer and indication) for Vabysmo in US; not checked against current local product information.
Vuity
pilocarpine ophthalmic · AbbVie Inc. (manufactured for); Allergan, an AbbVie company (US distributor)
Treats Age-related blurry near vision (presbyopia)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Vuity in US; not checked against current local product information.
Tepezza
teprotumumab-trbw · Horizon Therapeutics Ireland DAC
Treats Thyroid eye disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Tepezza in US; not checked against current local product information.
Syfovre
pegcetacoplan · Apellis Pharmaceuticals
Treats Geographic atrophy (advanced dry AMD)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Syfovre in US; not checked against current local product information.
Izervay
avacincaptad pegol · Astellas Pharma
Treats Geographic atrophy (advanced dry AMD)
Unverified catalogue summary (alternative identity, manufacturer and indication) for Izervay in US; not checked against current local product information.
Tyrvaya
varenicline · Oyster Point Pharma, Inc. (a Viatris company)
Treats Dry eye disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Tyrvaya in US; not checked against current local product information.
Miebo
perfluorohexyloctane · Bausch + Lomb
Treats Dry eye disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Miebo in US; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): RESTASIS cyclosporine 0.05% ophthalmic emulsion in 0.4 mL single-use vials; not RESTASIS MULTIDOSE or systemic cyclosporine
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- US label reference: Restasis US prescribing information — identity and company attribution
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
- US regulator product record (not a prescribing label): FDA original RESTASIS ophthalmic emulsion approval letter — December 23, 2002
Local licence · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
- DailyMed current labels for Restasis
- DailyMed current labels for Xiidra
- DailyMed current labels for Eylea
- DailyMed current labels for Vabysmo
- DailyMed current labels for Vuity
- DailyMed current labels for Tepezza
- DailyMed current labels for Syfovre
- DailyMed current labels for Izervay
- DailyMed current labels for Tyrvaya
- DailyMed current labels for Miebo
- FDA drug approvals and databases
- How TVPills researches and reviews content
Frequently asked questions
What drugs are similar to Restasis?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Restasis include other eye health medications advertised on TV such as Xiidra, Eylea, Vabysmo and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.
What can I take instead of Restasis?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other eye health medications advertised on TV include Xiidra, Eylea, Vabysmo and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Restasis. This page is informational only.
Is there a generic version of Restasis?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Restasis is sold as cyclosporine ophthalmic emulsion. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.
Are these alternatives the same as Restasis?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.